OBJECTIVE: Cancer patients have high levels of distress, yet oncologists often do not recognize patients' concerns. We sought to describe how patients with advanced cancer verbally express negative emotion to their oncologists. MATERIALS AND METHODS: As part of the Studying Communication in Oncologist-Patient Encounters Trial, we audio-recorded 415 visits that 281 patients with advanced cancer made to their oncologists at three US cancer centers. Using qualitative methodology, we coded for verbal expressions of negative emotion, identified words patients used to express emotion, and categorized emotions by type and content. RESULTS: Patients verbally expressed negative emotion in 17% of the visits. The most commonly used words were: "concern," "scared," "worried," "depressed," and "nervous." Types of emotion expressed were: anxiety (46%), fear (25%), depression (12%), anger (9%), and other (8%). Topics about which emotion was expressed were: symptoms and functional concerns (66%), medical diagnoses and treatments (54%), social issues (14%), and the health care system (9%). Although all patients had terminal cancer, they expressed negative emotion overtly related to death and dying only 2% of the time. CONCLUSIONS: Patients infrequently expressed negative emotion to their oncologists. When they did, they typically expressed anxiety and fear, indicating concern about the future. When patients use emotionally expressive words such as those we described, oncologists should respond empathically, allowing patients to express their distress and concerns more fully.
OBJECTIVE:Cancerpatients have high levels of distress, yet oncologists often do not recognize patients' concerns. We sought to describe how patients with advanced cancer verbally express negative emotion to their oncologists. MATERIALS AND METHODS: As part of the Studying Communication in Oncologist-Patient Encounters Trial, we audio-recorded 415 visits that 281 patients with advanced cancer made to their oncologists at three US cancer centers. Using qualitative methodology, we coded for verbal expressions of negative emotion, identified words patients used to express emotion, and categorized emotions by type and content. RESULTS:Patients verbally expressed negative emotion in 17% of the visits. The most commonly used words were: "concern," "scared," "worried," "depressed," and "nervous." Types of emotion expressed were: anxiety (46%), fear (25%), depression (12%), anger (9%), and other (8%). Topics about which emotion was expressed were: symptoms and functional concerns (66%), medical diagnoses and treatments (54%), social issues (14%), and the health care system (9%). Although all patients had terminal cancer, they expressed negative emotion overtly related to death and dying only 2% of the time. CONCLUSIONS:Patients infrequently expressed negative emotion to their oncologists. When they did, they typically expressed anxiety and fear, indicating concern about the future. When patients use emotionally expressive words such as those we described, oncologists should respond empathically, allowing patients to express their distress and concerns more fully.
Authors: H Ryan; P Schofield; J Cockburn; P Butow; M Tattersall; J Turner; A Girgis; D Bandaranayake; D Bowman Journal: Eur J Cancer Care (Engl) Date: 2005-03 Impact factor: 2.520
Authors: K B Wells; A Stewart; R D Hays; M A Burnam; W Rogers; M Daniels; S Berry; S Greenfield; J Ware Journal: JAMA Date: 1989-08-18 Impact factor: 56.272
Authors: Judith E Nelson; Elizabeth B Gay; Andrew R Berman; Charles A Powell; John Salazar-Schicchi; Juan P Wisnivesky Journal: Cancer Date: 2011-04-14 Impact factor: 6.860
Authors: Gil Bar-Sela; Sivan Yochpaz; Rachel Gruber; Doron Lulav-Grinwald; Inbal Mitnik; Dan Koren Journal: Support Care Cancer Date: 2015-06-12 Impact factor: 3.603
Authors: Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Christopher B Granger; Mark Crowther; Tracy Wang; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa; Jorge Pinto Ribeiro; Eduardo Darze; Renato A K Kalil; Marianna Andrande; Fabio Villas Boas; Jadelson Andrade; Ana Thereza Rocha; Robert A Harrington; Antonio C Lopes; David A Garcia Journal: J Thromb Thrombolysis Date: 2012-07 Impact factor: 2.300
Authors: Jane O Schell; Uptal D Patel; Karen E Steinhauser; Natalie Ammarell; James A Tulsky Journal: Am J Kidney Dis Date: 2012-01-04 Impact factor: 8.860
Authors: Renato D Lopes; Richard C Becker; John H Alexander; Paul W Armstrong; Robert M Califf; Mark Y Chan; Mark Crowther; Christopher B Granger; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Kenneth W Mahaffey; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; Antonio C Carvalho; Roberto R Giraldez; Helio P Guimaraes; Helena B Nader; Renato A K Kalil; Joyce M A Bizzachi; Antonio C Lopes; David A Garcia Journal: J Thromb Thrombolysis Date: 2011-08 Impact factor: 2.300
Authors: Stewart C Alexander; Susan Ladwig; Sally A Norton; David Gramling; J Kelly Davis; Maureen Metzger; Jane DeLuca; Robert Gramling Journal: J Palliat Med Date: 2014-03-03 Impact factor: 2.947
Authors: Anthony L Back; Wendy G Anderson; Lynn Bunch; Lisa A Marr; James A Wallace; Holly B Yang; Robert M Arnold Journal: Cancer Date: 2008-10-01 Impact factor: 6.860
Authors: Rachel A Rodenbach; Andrew D Althouse; Yael Schenker; Thomas J Smith; Edward Chu; Douglas B White; Marie Bakitas; Robert M Arnold Journal: J Pain Symptom Manage Date: 2020-09-12 Impact factor: 3.612